Clinical trialNCT02161757CompletedPhase 3Interventional

A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma

SponsorAstraZenecaEnrollment1,207Uncontrolled Asthma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Reynold A Panettieri, M.D.
University of Pennsylvania
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

243 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site
Buenos Aires, Argentina
Research Site
CABA, Argentina
Research Site
Cap. Fed, Argentina
Research Site
Ciudad Autonomade Buenos Aires, Argentina
Research Site
Concepción del Uruguay, Argentina
Research Site
Córdoba, Argentina
Research Site
Mendoza, Argentina
Research Site
Mendoza, Argentina
Research Site
Quilmes, Argentina
Research Site
Rosario, Argentina
Research Site
San Miguel de Tucumán, Argentina

Belgium

Research Site
Brussels (Anderlecht), Belgium
Research Site
Erpent, Belgium
Research Site
Leuven, Belgium
Research Site
Liège, Belgium

Bulgaria

Research Site
Dupnitsa, Bulgaria
Research Site
Kozloduy, Bulgaria
Research Site
Pazardzhik, Bulgaria
Research Site
Pernik, Bulgaria
Research Site
Rousse, Bulgaria
Research Site
Sliven, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Stara Zagora, Bulgaria
Research Site
Varna, Bulgaria
Research Site
Veliko Tarnovo, Bulgaria
Research Site
Vratsa, Bulgaria
Research Site
Yambol, Bulgaria

Colombia

Research Site
Armenia, Colombia
Research Site
Bogotá, Colombia
Research Site
Bogotá, Colombia
Research Site
Cali, Colombia

Germany

Research Site
Aschaffenburg, Germany
Research Site
Augsburg, Germany
Research Site
Bad Lippspringe, Germany
Research Site
Geesthacht, Germany
Research Site
Herford, Germany
Research Site
Landsberg, Germany
Research Site
Leipzig, Germany

203 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 13 Jun 2014
Primary completion: 28 Feb 2017
Completion: 18 Jul 2017
Last update posted: 28 Aug 2018
Registered enrollment: 1,207
Registry id: NCT02161757

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.